CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 90 enrolled
Drug / intervention
Optimal insulin injectionbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04120974
NCT04120974N/ACompleted
CompareCT.gov

The Role of Proper Insulin Injection Technique in the Treatment of Diabetes

Becton, Dickinson and Company·interventional·Posted Oct 9, 2019·Updated Feb 22, 2024

In Brief

A clinical study evaluating Optimal insulin injection for Diabetes Mellitus, Type 2 and 2 related conditions. Completed, enrolled 90 participants across 4 sites.

Detailed Summary

This is a prospective, post-marketing, single-arm clinical investigation on the effects of optimal insulin injection technique, in conjunction with the use of disposable Becton Dickinson (BD) Micro-Fine Plus 32G pen needles, by Type I and Type II Diabetes Mellitus patients, with or without lipohypertrophy, on clinical outcomes like HbA1c and hypoglycemic events, as well as changes in insulin Total Daily Dose (TDD) and patient's Quality of Life (QoL). During this study, each subject will be trained in the optimal insulin injection technique by personal training as well as by following online video training modules on a specific web-based platform.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type 2, Diabetes Mellitus, Type 1, Lipohypertrophy
CountriesRussia
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedOct 9, 2019
Enrollment StartOct 1, 2019
Primary CompletionApr 26, 2021
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 6.7 years ago

Interventions

Optimal insulin injectionbehavioral

subjects receive training in optimal injection technique.